Peritoneal cytokines predict mortality after surgical treatment of secondary peritonitis in the rat

Journal of the American College of Surgeons

Volumn 211, Issue 2, 2010, Pages 263-270

  Hendriks, Thijs ^a   Bleichrodt, Robert P ^a   Lomme, Roger M L M ^a   De Man, Ben M ^a   Van Goor, Harry ^a   Buyne, Otmar R ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BACTERIUM; CORRELATION ANALYSIS; DEBRIDEMENT; DISEASE SEVERITY; DYING; EXPERIMENTAL MODEL; MALE; NONHUMAN; PATIENT DECISION MAKING; PATIENT IDENTIFICATION; PERITONEAL FLUID; PERITONITIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SAMPLING; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME; ANIMAL; ASCITES FLUID; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; LAPAROTOMY; METABOLISM; MORTALITY; PERITONEUM; PREDICTIVE VALUE; PROGNOSIS; SURVIVAL RATE; TRENDS; WISTAR RAT;

ANIMALS; ASCITIC FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-10; INTERLEUKIN-6; LAPAROTOMY; MALE; PERITONEUM; PERITONITIS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955555027     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2010.03.038     Document Type: Article

References (27)

1. J.C. Marshall, and M. Innes Intensive care unit management of intra-abdominal infection Crit Care Med 31 2003 2228 2237
2. J.W. van Till, S.Q. van Veen, and O. van Ruler The innate immune response to secondary peritonitis Shock 28 2007 504 517
3. K.R. Walley, N.W. Lukacs, and T.J. Standiford Balance of inflammatory cytokines related to severity and mortality of murine sepsis Infect Immun 64 1996 4733 4738
4. S. Ebong, D. Call, and J. Nemzek Immunopathologic alterations in murine models of sepsis of increasing severity Infect Immun 67 1999 6603 6610
5. R.G. Holzheimer, M. Schein, and D.H. Wittmann Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis Arch Surg 130 1995 1314 1319
6. R. Herwig, B. Glodny, and C. Khle Early identification of peritonitis by peritoneal cytokine measurement Dis Colon Rectum 45 2002 514 521
7. D. Frhlich, R.M. Eiber, M. Jochum, and A. Billing Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-alpha, and granulocyte elastase release in human secondary peritonitis Cytokine 9 1997 288 292
8. S. Scheingraber, F. Bauerfeind, J. Bhme, and H. Dralle Limits of peritoneal cytokine measurements during abdominal lavage treatment for intraabdominal sepsis Am J Surg 181 2001 301 308
9. L. Martineau, and P.N. Shek Peritoneal cytokine concentrations and survival outcome in an experimental bacterial infusion model of peritonitis Crit Care Med 28 2000 788 794
10. O.R. Buyne, R.P. Bleichrodt, and P.E. Verweij A peritonitis model with low mortality and persisting intra-abdominal abscesses Int J Exp Pathol 87 2006 361 368
11. O.R. Buyne, R.P. Bleichrodt, and H. van Goor Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model Int J Colorectal Dis 22 2007 819 825
12. O.R. Buyne, H. van Goor, and R.P. Bleichrodt Both tissue-type plasminogen activator and urokinase prevent intraabdominal abscess formation after surgical treatment of peritonitis in the rat Surgery 144 2008 66 73
13. O.R. Buyne, R.P. Bleichrodt, and H. van Goor Plasminogen activator, but not systemic antibiotic therapy, prevents abscess formation in an experimental model of secondary peritonitis Br J Surg 95 2008 1287 1293
14. O.R. Buyne, H. van Goor, and P.E. Verweij Timing and dose of tissue plasminogen activator to prevent abscess formation after surgical treatment of secondary peritonitis in the rat Surg Innov 16 2009 299 305
15. V. Bewick, L. Cheek, and J. Ball Statistics review 13: receiver operating characteristic curves Crit Care 8 2004 508 512
16. K. Emmanuel, H. Weighardt, and H. Bartels Current and future concepts of abdominal sepsis World J Surg 29 2005 3 9
17. N. Zgel, M. Siebeck, and B. Geissler Circulating mediators and organ function in patients undergoing planned relaparotomy vs conventional surgical therapy in severe secondary peritonitis Arch Surg 137 2002 590 599
18. K. Jansson, B. Redler, and L. Truedsson Intraperitoneal cytokine response after major surgery: higher postoperative intraperitoneal versus systemic cytokine levels suggest the gastrointestinal tract as the major source of the postoperative inflammatory reaction Am J Surg 187 2004 372 377
19. P. Matthiessen, I. Strand, and K. Jansson Is early detection of anastomotic leakage possible by intraperitoneal microdialysis and intraperitoneal cytokines after anterior resection of the rectum for cancer? Dis Colon Rectum 50 2007 1918 1927
20. C.L. Verdant, M. Chierego, and V. De Moor Prediction of postoperative complications after urgent laparotomy by intraperitoneal microdialysis: A pilot study Ann Surg 244 2006 994 1002
21. H. Kørner, H.J. Nielsen, and J.A. Søreide Diagnostic accuracy of C-reactive protein for intraabdominal infections after colorectal resections J Gastrointest Surg 13 2009 1599 1606
22. R.L. Bracho-Riquelme, M.A. Reyes-Romero, and N. Pescador A leptin serum concentration less than 10 ng/ml is a predictive marker of outcome in patients with moderate to severe secondary peritonitis Eur Surg Res 41 2008 238 244
23. B.M. Rau, I. Frigerio, and M.W. Bchler Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study Arch Surg 142 2007 134 142
24. C.P. Schneider, Y. Yilmaz, and A. Kleespies Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients Shock 31 2009 568 573
25. L.F. Poli-de-Figueiredo, A.G. Garrido, N. Nakagawa, and P. Sannomiya Experimental models of sepsis and their clinical relevance Shock 30 2008 53 59
26. D.G. Remick, G.R. Bolgos, and J. Siddiqui Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days Shock 17 2002 463 467
27. R.M. Determann, J.W. van Till, and O. van Ruler sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis Cytokine 46 2009 36 42